Krumbiegel P, Hirschberg K, Faust H, Günther K, Schneider G
Eur J Nucl Med. 1985;11(2-3):58-61. doi: 10.1007/BF00252133.
A simple, non-invasive, non-radioactive liver-function test is proposed. After an oral dose of 3 mg 15N-methacetin per kilogram body mass, the kinetics of 15N excretion via urine were characterized by the quotient of the amounts of 15N excreted in two successive urine samples (Q value). The stable nitrogen isotope 15N was found to be an excellent and easily detectable indicator of the sum of all methacetin metabolites present in urine. Alterations in the nature or ratio of methacetin metabolites due to liver diseases could not be found. From the investigation of 11 men, 3 pregnant women and 15 children, a clear difference was observed in Q values of healthy persons and patients suffering from liver-cell-activity diseases. The discriminating power of our new liver-function test is shown to be equivalent to that of the 14CO2 breath test.
提出了一种简单、无创、无放射性的肝功能测试方法。口服每千克体重3毫克的15N-甲氧基乙酰苯胺后,通过连续两个尿液样本中排出的15N量的商(Q值)来表征15N经尿液排泄的动力学。发现稳定氮同位素15N是尿液中所有甲氧基乙酰苯胺代谢物总和的极佳且易于检测的指标。未发现肝脏疾病导致的甲氧基乙酰苯胺代谢物性质或比例的改变。在对11名男性、3名孕妇和15名儿童的研究中,观察到健康人和患有肝细胞活性疾病的患者的Q值存在明显差异。我们新的肝功能测试的鉴别能力与14CO2呼气测试相当。